Statement of work The Broad Institute will support the work of BADERC investigators through engagement of the following Broad Platforms: Metabolite Profiling, Proteomics, RNAi and Genetic Analysis. We propose two modes in which BADERC investigators can utilize this support: First is through the pre-existing Pilot and Feasibility process. We envision that a number of these P&F proposals will aim to incorporate Broad platform capabilities in their proposals (for example, a project that performs metabolic profiling and / or RNAi screening capabilities, or that utilizes SNP genotyping in a human genetic aims with the Genetic Analysis Platform). The Project Manager (Ms. Burtt) and PI (Altshuler) will help investigators identify and engage these opportunities, to interact with platform staff to assess feasibility and details of experimental design, and to write proposals utilizing these platforms. If these P&F proposals are judged meritorious and selected for funding (by the existing BADERC mechanism), then the costs incurred by the Broad platforms would be supported by the budgeted funds. The program manager would then facilitate the execution of the approved project activities. Second, there are a number of platform capabilities that will be available to BADERC investigators as needed based on their existing research. Examples might include SNP genotyping for an ongoing project that tests whether a novel candidate gene contributes to a diabetes-related phenotype in humans, or creation of new RNAi reagents to perform knock-down assays in a cellular diabetes model. The Broad subcontract will support access to such Broad platform capabilities by each BADERC investigator (up to a pre-specified limit per investigator, not to exceed the total budgeted). As above, the project manager would serve as a key liaison between BADERC investigators and Broad Platforms, helping identify which capabilities matched each funding mechanism, guiding investigators to the relevant staff, and facilitating successful execution of each approved activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK057521-13
Application #
8378793
Study Section
Special Emphasis Panel (ZDK1-GRB-2)
Project Start
Project End
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
13
Fiscal Year
2012
Total Cost
$126,980
Indirect Cost
$20,223
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Vujic, Ana; Lerchenmüller, Carolin; Wu, Ting-Di et al. (2018) Exercise induces new cardiomyocyte generation in the adult mammalian heart. Nat Commun 9:1659
Fulzele, Keertik; Dedic, Christopher; Lai, Forest et al. (2018) Loss of Gs? in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity. Bone 117:138-148
Battistone, Maria A; Nair, Anil V; Barton, Claire R et al. (2018) Extracellular Adenosine Stimulates Vacuolar ATPase-Dependent Proton Secretion in Medullary Intercalated Cells. J Am Soc Nephrol 29:545-556
Cheung, Pui W; Terlouw, Abby; Janssen, Sam Antoon et al. (2018) Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation. J Physiol :
Karim, Lamya; Moulton, Julia; Van Vliet, Miranda et al. (2018) Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes. Bone 114:32-39
Kolar, Matthew J; Nelson, Andrew T; Chang, Tina et al. (2018) Faster Protocol for Endogenous Fatty Acid Esters of Hydroxy Fatty Acid (FAHFA) Measurements. Anal Chem 90:5358-5365
Todd, William D; Fenselau, Henning; Wang, Joshua L et al. (2018) A hypothalamic circuit for the circadian control of aggression. Nat Neurosci 21:717-724
Cox, Kimberly H; Oliveira, Luciana M B; Plummer, Lacey et al. (2018) Modeling mutant/wild-type interactions to ascertain pathogenicity of PROKR2 missense variants in patients with isolated GnRH deficiency. Hum Mol Genet 27:338-350
Aguayo-Mazzucato, Cristina; Bonner-Weir, Susan (2018) Pancreatic ? Cell Regeneration as a Possible Therapy for Diabetes. Cell Metab 27:57-67
McKeown, Nicola M; Dashti, Hassan S; Ma, Jiantao et al. (2018) Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis. Diabetologia 61:317-330

Showing the most recent 10 out of 389 publications